Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.54 |
| ▸ | GSK3A | P49840 | 3/20 | 0.54 |
| ▸ | GSK3B | P49841 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12307220 | 0.84 | MEN1 (0.51) | MEN1KMT2AGSK3AGSK3BGAA | |
| SCHEMBL6081224 | 0.80 | KMT2A (0.56) | MEN1KMT2AGSK3AGSK3BALDH1A1 | |
| SCHEMBL12307050 | 0.74 | MEN1 (0.41) | MEN1KMT2AGSK3AGSK3BGAA | |
| SCHEMBL1421312 | 0.73 | GSK3A (0.67) | MEN1KMT2AGSK3AGSK3BGAA | |
| SCHEMBL21295029 | 0.73 | ALDH1A1 (0.48) | MEN1KMT2AGAAALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL22092329 | 0.72 | GSK3A (0.65) | MEN1KMT2AGSK3AGSK3BGAA | |
| SCHEMBL14081287 | 0.72 | MEN1 (0.65) | MEN1KMT2AGSK3AGSK3BGAA | |
| Rhodanine-3-Acetic Acid SCHEMBL2121316 | 0.70 | GSK3A (1.00) | MEN1KMT2AGSK3AGSK3BGAA | |
| Rhodanine-3-Acetic Acid SCHEMBL250012 | 0.70 | GSK3A (1.00) | MEN1KMT2AGSK3AGSK3BGAA | |
| Rhodanine-3-Acetic Acid SCHEMBL1372027 | 0.69 | GSK3A (0.96) | MEN1KMT2AGSK3AGSK3BGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9801960-B2 | Probe for a biological specimen and labelling method and screening method using the probe | CANON KABUSHIKI KAISHA (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9801960-B2 | Probe for a biological specimen and labelling method and screening method using the probe | CANON KABUSHIKI KAISHA (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20150157745-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | CANON KK (JP) | 2015-06-11 | — | — | US | disclosed |
| US-20150157745-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | CANON KK (JP) | 2015-06-11 | — | — | US | disclosed |
| US-20150076420-A1 | Dye-Sensitized Photoelectric Conversion Element | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8735720-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20110243850-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110243850-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20090044857-A1 | Dye-Sensitized Photoelectric Conversion Device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090044857-A1 | Dye-Sensitized Photoelectric Conversion Device | CRY1, H1-5, CHRM1 | MEN1 505/4885KMT2A 435/4885GSK3A 4528/4885 |
| US-20150157745-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | FUCA1, FABP2, ALPI | MEN1 1003/4885KMT2A 4373/4885GSK3A 4603/4885 |
| US-20110243850-A1 | PROBE FOR A BIOLOGICAL SPECIMEN AND LABELLING METHOD AND SCREENING METHOD USING THE PROBE | FUCA1, FABP2, ALPI | MEN1 1003/4885KMT2A 4373/4885GSK3A 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.